September 2021

First At-Home COVID-19 Test Gains Emergency Use Authorization
The FDA recently issued an Emergency Use Authorization for an at-home COVID-19 test manufactured by Becton, Dickinson and Company. The At-Home COVID-19 Test is the first at-home COVID-19 rapid antigen test to use computer vision technology in a smartphone to interpret and provide a digital display of results. The novel test does not require a prescription. Read more.
Advertisement

Study Suggests Insomnia and Migraines Have a Causal Relationship
New findings from a study published in Pharmacogenomics and Personalized Medicine suggest that individuals with a genetic predisposition to insomnia have a greater incidence of migraines Researchers conducted the case-control study and bidirectional mendelian randomization analysis to ascertain whether the sleep disorder is causally related to the development of the chronic headache condition. Read more.

Increased Vitamin D Linked to Lower Early-Onset Colorectal Cancer Risk
Results from a recent study published in Gastroenterology indicate that an increased intake of vitamin D is associated with a decreased risk of early-onset colorectal cancer (CRC). Researchers examined the association between total vitamin D intake and risks of early-onset CRC and precursors and among women enrolled in the Nurses' Health Study II. Read more.

Connect With U.S. Pharmacist
Facebook Twitter USP Google AppUSP Itunes App